Bio-Rad Launches New Line of Thermal Cyclers for PCR Applications
The PTC Harmony 96 and PTC Harmony Deepwell systems are designed to provide high-performance PCR for academic and biopharma laboratories.
The PTC Harmony 96 and PTC Harmony Deepwell systems are designed to provide high-performance PCR for academic and biopharma laboratories.
Research shows optical genome mapping identifies genomic changes in nearly 98% of T-cell acute lymphoblastic leukemia cases compared to 55% with traditional analysis.
A new position statement warns that albumin-adjusted calcium formulas are unreliable and may lead to patient misclassification.
The FDA has granted Breakthrough Device Designation to Valar Labs’ Vesta Bladder Risk Stratify Dx, the first AI-powered digital pathology prognostic test for bladder cancer.
The panel integrates biomarker testing and digital tools to support fibrosis risk assessment and liver cancer surveillance.
The study identifies HAVCR1 as a tool for earlier detection and treatment monitoring for primary central nervous system lymphoma.
Bio-Rad has expanded its TrailBlazer StarBright Dye Label Kits to 32 options, now available in Europe for flow cytometry and fluorescent western blot applications, according to the company.
The XR-Series features higher throughput and enhanced analytics to streamline daily laboratory operations.
Roche has received CE mark approval for its Elecsys pTau217 blood test, designed to aid in Alzheimer’s disease diagnosis by detecting amyloid pathology in patients with cognitive decline.
The new triple quadrupole mass spectrometry system aims to increase sample throughput and simplify interference removal.
New research indicates that standard and modified two-tiered testing algorithms fail to detect infection in up to 78% of patients during the early stages of the disease.
The new 3B-NEO service uses whole exome and whole genome sequencing to identify risks for serious childhood-onset disorders before symptoms appear.
The cobas liat system delivers PCR results in 15 minutes, detecting and differentiating between three Bordetella pathogens including whooping cough.
The screening tool identifies specific molecules produced by gut bacteria to distinguish children with autism from typically developing peers.